Purchase Order 75N91020P00771
Award Date 9/10/20
Potential Completion Date 4/7/25
Potential Value $190K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Life Technologies Corporation (doing business as Thermo Fisher Scientific) to provide service and maintenance for two government-owned ABI Genetic Analyzer 3500XL instruments. The contract has a ceiling value of $138,401.36 and a period of performance from April 15, 2021 through April 15, 2026, with four 12-month option periods. The purchase order does not...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a firm fixed price Blanket Purchase Agreement (BPA) call for service agreement support of the 3500XL Genetic Analyzer by the National Cancer Institute. The contract, valued at $15,630.04, was awarded on November 23, 2023, with an ultimate completion date of November 22, 2024. Performance will be conducted at the National Cancer Institute's facility in Rockville, Maryland. This award represents a...
- The National Cancer Institute awarded a one-year firm fixed-price service contract to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on December 10, 2018, for preventative maintenance and support services on a genetic analyzer (Serial #16901-013). The contract, valued at $12,359.96, was executed through a Blanket Purchase Agreement (BPA) call and carries no set-aside designation, reflecting the contractor's competitive positioning in federal scientific procurement....
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on January 3, 2017, for a service agreement supporting a 7900HT sequencer. The contract, valued at $7,193.92 with an ultimate completion date of January 15, 2018, was awarded without a set-aside designation. Performance will be conducted at the NCI's facility in Bethesda, Maryland. This award represents a...
- This is a federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the purchase of a 3500XL Genetic Analyzer instrument. The contract is a firm fixed-price purchase order with a ceiling value of $16,642.52, awarded by the National Institutes of Health (NIH) Clinical Center. The contract does not have a set-aside designation and is for the delivery of the genetic analysis instrument to be completed by September 27, 2026. Life Technologies...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $145,864.22 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the acquisition of a flow cytometry instrument with autosampler. The instrument will be used by NCI's Division of Cancer Epidemiology and Genetics Laboratory of Translational Genomics to study the genetic basis of cancer. The purchase order has a...
- This $19,905 firm fixed-price purchase order was awarded to Life Technologies Corporation (a division of Thermo Fisher Scientific) by the National Cancer Institute, a civilian agency under the Department of Health and Human Services. The contract is for the provision of Life Technologies' scientific instruments, reagents, and consumables to support the NCI's biomedical research, medical readiness, and other initiatives. This award is not associated with a set-aside program. Life Technologies has...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on June 23, 2016, with a ceiling value of $5,244.76 and an ultimate completion date of July 7, 2017. The award was made without a set-aside designation and is to be performed at the NCI's Bethesda, Maryland facility. As a prominent manufacturer of scientific instruments, reagents, and consumables, Life...
- This firm fixed-price purchase order with a ceiling value of $226,971.36 was awarded by the National Cancer Institute (NCI), a civilian agency, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a laser capture microdissection instrument and related services. The contract is not designated as a set-aside. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on November 29, 2017, with a ceiling value of $6,698.28 and an ultimate completion date of December 31, 2018. The contract, which carries no set-aside designation, reflects Life Technologies' established competitive position as a leading supplier of scientific instruments and laboratory equipment to federal...